2024年國際 SCI 論文
| 編號 | 篇名 | 作者 | 期刊 | 卷期 |
| 1 | Comparative effectiveness and safety of inhaled corticosteroid plus long-acting β2-agonist fixed-dose combinations vs. long-acting muscarinic antagonist in bronchiectasis | Su VY, Ding TL, Chang YL, Chou YC, Hwang HE, Chou CY, Hsu CC | Expert Rev Clin Pharmacol | 2024;17(2):157-164. |
| 2 | A novel Multi-Level Refined (MLR) knowledge graph design and chatbot system for healthcare applications | Hsueh HC, Chien SC, Huang CW, Yang HC, Iqbal U, Lin LF, Jian WS | PLoS One | 2024;19(1):e0296939 |
| 3 | Mitochondrial dysfunction decreases cisplatin sensitivity in gastric cancer cells through upregulation of integrated stress response and mitokine GDF15 | Wang SF, Chang YL, Liu TY, Huang KH, Fang WL, Li AFY, Yeh TS, Hung GY, Lee HC | FEBS J | 2024;291(6):1131-1150. |
| 4 | Safety and effectiveness of remdesivir in hospitalized patients with COVID-19 and severe renal impairment: experience at a large medical center | Chang HY, Hsu CC, Hu LF, Chou CY, Chang YL, Lu CC, Chang LJ | Ann Med | 2024;56(1):2361843 |
| 5 | Effectiveness and safety of non-vitamin K antagonist oral anticoagulants in low-weight patients with atrial fibrillation | Chen KH, Hsu YY, Chou CY, Hsu CC, Chang SL, Yu WC, Chang YL | J Thromb Thrombolysis | 2024 Accepted |
2024年非 SCI 論文
|
編號 |
篇名 |
作者 |
期刊 |
卷期 |
|---|---|---|---|---|
| 1 | 肝動脈栓塞化療用於肝癌之用藥探討 | 施立于、王笙帆、陳奇良 | 醫院藥學 | 2024; 41:1-12 |
| 2 | 疑似Levofloxacin相關的QTc間隔延長 | 黃偉倫、王笙帆、陳奇良 | 醫院藥學 | 2024; 41:13-18 |
| 3 | Pemigatinib用於轉移性膽管癌之病例用藥探討 | 胡晉嘉、蔡涵怡 | 醫院藥學 | 2024; 41:19-26 |
| 4 | 急性心衰竭Sacubitril/Valsartan與SGLT2 inhibitors使用時機之用藥探討 | 翁如潔、王笙帆、何沁沁 | 醫院藥學 | 2024; 41:27-31 |
| 5 | 缺血性腦中風之血脂異常治療 | 黃冠慈、陳寬軒、周千瀅 | 醫院藥學 | 2024; 41:32-37 |
| 6 | 心衰竭治療新藥-Dapagliflozin | 胡藜方、陳寬軒、蔡涵怡 | 醫院藥學 | 2024; 41:38-43 |
| 7 | Lemborexant全新機轉治療失眠新選擇 | 盧孟穗、王斯郁 | 醫院藥學 | 2024; 41:44-50 |
| 8 | 延長piperacillin-tazobactam靜脈輸注時間用於重症病人之療效探討 | 張賀凱、張豫立、周千瀅 | 醫院藥學 | 2024; 41:51-56 |
最後更新：